Igor I. Averkin

Igor I. Averkin

Auto-generated profile, based on publicly available information

Igor I. Averkin

Almazov National Medical Research Centre, Health Ministry of Russian Federation

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 June 2020 in The Journal of Maternal-Fetal & Neonatal Medicine
Verified
Journal Article
Closed access
IAIgor I. Averkin
Igor I. Averkin
EGEvgeny V. Grehov
Evgeny V. Grehov
TPTat’yana M. Pervunina
Tat’yana M. Pervunina
EKEduard V. Komlichenko
Eduard V. Komlichenko
EVElena S. Vasichkina
Elena S. Vasichkina
VTValentina Tsibizova
Valentina Tsibizova
The application of the 3D printing approach in medicine is currently becoming increasingly popular. The management of fetuses and newborns with congenital heart defects is often difficult, primarily due to the complexity of the anatomy. Here we report a newborn with a complex congenital malformation (absent pulmonary valve syndrome associated with tetralogy of Fallot), which could be clinically interpreted in different ways. 3D printing allowed to elucidate the exact anatomy more precisely and direct the cardiosurgeon to a definitive treatment.

19 March 2021 in Journal of Cardiac Surgery
Verified
Journal Article
Closed access
PDF file
IKIvan A. Kozyrev
Ivan A. Kozyrev
NKNikolai A. Kotin
Nikolai A. Kotin
IAIgor I. Averkin
Igor I. Averkin
AIAndrey A. Ivanov
Andrey A. Ivanov
ALAlexander A. Latypov
Alexander A. Latypov
EGEvgeny V. Grekhov
Evgeny V. Grekhov

24 April 2020 in FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology
Verified
Journal Article
Open access
PDF file
VTValentina Tsibizova
Valentina Tsibizova
IGIgor Govorov
Igor Govorov
IAI. I. Averkin
I. I. Averkin
NKN. M. Khamani
N. M. Khamani
DBDmitry V. Blinov
Dmitry V. Blinov
Introduction.Twin reversed arterial perfusion (TRAP) syndrome is one of the types of complications of monochorial twins (MT) with a frequency of occurrence of 1:35000 births. It is characterized by the presence of the main vessel instead of a normal 4 chambers heart and intrauterine developmental abnormalities. This pregnancy requires monitoring using dynamic ultrasound diagnostics every 7 days, in accordance with current recommendations. The treatment is intrauterine laser coagulation of blood vessels of the “acardial fetus” (AP) in order to prevent the development of a threatening condition for the “fetal pump” (PP). Aim: to demonstrate the possibilities of comprehensive conservative management of monochorial pregnancy complicated by TRAP.Materials and methods. An ultrasound examinations were performed on a weekly basis in monochorionic pregnancy, complicated by TRAP within the period 12-38 weeks. Serum concentrations of biochemical markers PAPP-A (pregnancy-associated plasma protein-A) and β-hGC (β-subunit of human chorionic gonadotropin) were studied in the first trimester to predict adverse perinatal outcomes.Results. The possibility of prolonging a pregnancy complicated by TRAP without performing intrauterine surgical intervention, during which quite serious complications can occur in this category of pregnancies, has been demonstrated. In a patient with monochorionic twins complicated by TRAP, totally 27 ultrasound examinations were performed within the period 12-38 weeks. This approach made it possible to dynamically monitor the condition of a pregnant and healthy fetus and to prolong pregnancy without surgery until the full term.Conclusions.Following the existing guidelines, without tailoring for individual risk, may lead to an unreasonable increase in surgical interventions. In turn, surgery is not only accompanied by a high risk of complications (up to 15%), but also constitute a certain financial burden on the budget, determined by the state on the level of 208,000 rubles. Performing routine ultrasound examinations according to the examination protocol for monochorionic pregnancy will contribute to avoiding the complications associated with surgery and better selection for surgery as well as reducing the government costs.

7 March 2022 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
VTValentina Tsibizova
Valentina Tsibizova
TPTatiana Pervunina
Tatiana Pervunina
VAV. A. Artemenko
V. A. Artemenko
VBVictoria Bitsadze
Victoria Bitsadze
KGK. E. Gotsiridze
K. E. Gotsiridze
NNN. Yu. Novikova
N. Yu. Novikova
It has been increasingly recognized that structural abnormalities and functional changes in the placenta can adversely affect developing fetal heart. In this article, we examine a role of the placenta as well as potential impact of placental insufficiency on a fetus with congenital heart disease (CHD). The fetal heart and placenta are directly connected because they develop simultaneously with common regulatory and signaling pathways. Moreover, placenta-associated complications are more common in pregnant women carrying fetus with CHD, and the fetal response to placental insufficiency may lead to postnatal preservation of remodeled heart. The mechanisms underlying this placenta–fetus axis potentially consists of genetic factors, oxidative stress, chronic hypoxia, and/or angiogenic imbalance. Thus, the mother–placenta–fetus circulation is critical in understanding the CHD formation. It is necessary to study the changing factors involved in these processes for early identification, imaging, quantification of placental insufficiency, and development of new prenatal therapies in the CHD patient population.

5 May 2021 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
VTValentina Tsibizova
Valentina Tsibizova
IAI. I. Averkin
I. I. Averkin
VBVictoria Bitsadze
Victoria Bitsadze
AKA. V. Kozlenok
A. V. Kozlenok
EGE. V. Grekhov
E. V. Grekhov
DBDmitry V. Blinov
Dmitry V. Blinov
Assessment of fetal cardiac function is one of the essential components of fetal echocardiography. Functional impairment is associated with a high risk of adverse perinatal outcomes and even antenatal death. Prenatal detection of hemodynamics changes requires immediate prenatal actions to identify the causes and eliminate the consequences that may require conservative treatment, intrauterine surgical treatment, and early delivery in perinatal centers.

11 January 2021 in Obstetrics, Gynecology and Reproduction
Verified
Journal Article
Open access
PDF file
VTValentina Tsibizova
Valentina Tsibizova
DBDmitry V. Blinov
Dmitry V. Blinov
VBVictoria Bitsadze
Victoria Bitsadze
TPTatiana Pervunina
Tatiana Pervunina
EKE. V. Komlichenko
E. V. Komlichenko
IAI. I. Averkin
I. I. Averkin
Introduction. Perinatal mortality in multiple pregnancies increases by 8–10 times compared to singletons. Stillbirth is a significant part of all complications of multiple pregnancies. Although the incidence of perinatal mortality in multiple pregnancies has decreased consistently compared to extremely high rates in the past, it remains relatively high, despite significant positive changes in the management of such pregnancies. Aim: to assess the diagnostic potential of the first trimester's biochemical screening in multiple pregnancies for predicting antenatal fetal death. Materials and Methods. As part of a retrospective study, a cohort of twin pregnancies after in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), or spontaneous conception underwent screening of the first trimester at 11+0–13+6 weeks of gestation as recommended by the Fetal Medicine Foundation. Determination of pregnancy-associated plasma protein-A (PAPP-A) in blood serum with subsequent calculation of the relative PAPP-A MoM (multiples of median) – a multiple of the median (an indicator of how much the individual test result deviates from the reference values) was performed. Results. Prenatal screening and outcomes of 302 multiple pregnancies showed that with PAPP-A MoM < 0.5, antenatal fetal death occurred with a frequency of 42.86 % (6/14), with PAPP-A MoM within the reference values – In 12.67 % (28/221), with PAPP-A MoM > 2.0 – in 6.7 % (2/30). Differences between patients with PAPP-A MoM < 0.5 and PAPP-A MoM within the reference values, as well as PAPP-A MoM < 0.5 and PAPP-A MoM > 2.0 were statistically significant (p = 0.002 and p = 0.004, respectively). No differences were detected between spontaneous and assisted reproductive technology (ART) pregnancies. Conclusion. In women with multiple pregnancies resulting from ART or spontaneous, PAPP-A MoM values below the reference interval (< 0.5) in the first trimester are associated with an increased risk of antenatal fetal death.